EichorEICHOR
Condition: Alzheimer Disease 2 Synced from ClinicalTrials.gov · August 04, 2026

Recruiting studies: Alzheimer Disease 2

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Phase 2 · 72 location(s) · Eli Lilly and Company · NCT07589595
Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging Study
Phase N/A · 1 location(s) · Rigshospitalet, Denmark · NCT07482072
The Swedish BioFINDER 2 Study
NA · 2 location(s) · Skane University Hospital · NCT03174938
Infrared Light for Memory Loss in Mild Cognitive Impairment (MCI)
NA · 1 location(s) · Unity Health Toronto · NCT06618807
A Study of AMDX-2011P in Participants With Alzheimer's Disease
Phase 2 · 1 location(s) · Amydis Inc. · NCT06514001
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Phase 2 · 79 location(s) · Merck Sharp & Dohme LLC · NCT07033494
Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disea
Phase N/A · 1 location(s) · Neuromed IRCCS · NCT07467460
NYSCF Scientific Discovery Biobank
Phase N/A · 1 location(s) · New York Stem Cell Foundation Research Institute · NCT06203106
A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK
Phase 1 · 2 location(s) · University College, London · NCT06372821
Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients
NA · 2 location(s) · Icahn School of Medicine at Mount Sinai · NCT05016219
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by
Phase 2/Phase 3 · 37 location(s) · Washington University School of Medicine · NCT05552157
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
Phase 1/Phase 2 · 26 location(s) · AC Immune SA · NCT05462106
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Phase 2/Phase 3 · 49 location(s) · Exciva GmbH · NCT07284472
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
NA · 2 location(s) · Indiana University · NCT05733520
Dominantly Inherited Alzheimer Network (DIAN)
Phase N/A · 26 location(s) · Washington University School of Medicine · NCT00869817
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants W
Phase 2 · 53 location(s) · Celgene · NCT06808984
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by
Phase 2/Phase 3 · 37 location(s) · Washington University School of Medicine · NCT06647498
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET
Phase 3 · 126 location(s) · Bristol-Myers Squibb · NCT06976203
Clinical Trial on Agitation in Alzheimer's Dementia
Phase 2 · 31 location(s) · IGC Pharma, LLC · NCT05543681
Late Onset Alzheimer's Disease
Phase N/A · 12 location(s) · Columbia University · NCT05010603
Alzheimer's Disease Genetics Study
Phase N/A · 1 location(s) · Indiana University · NCT00064870
The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's Diseas
NA · 8 location(s) · Alzheimercentrum Amsterdam · NCT07680335
A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease P
Phase 2 · 2 location(s) · Elixiron Immunotherapeutics Inc. · NCT06745583
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
Phase 1/Phase 2 · 3 location(s) · Ashvattha Therapeutics, Inc. · NCT05395624
The BRAIN App (Phase 2 SBIR)
NA · 1 location(s) · Hopeful Aging · NCT06298474
A Study of Oral EX039 in Subjects with Mild Alzheimer's Disease
Phase 2 · 1 location(s) · Excelsior · NCT05413655
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →